<DOC>
	<DOCNO>NCT01653821</DOCNO>
	<brief_summary>The aim study determine safety , tolerability feasibility unilateral bilateral carotid body excision patient systolic heart failure peripheral chemoreceptor hypersensitivity .</brief_summary>
	<brief_title>Surgical Removal Carotid Body Patients With Systolic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Heart Failure , Systolic</mesh_term>
	<criteria>History heart failure class IIIII accord NYHA within least 6 month prior inclusion Stable clinical state within least 4 week prior inclusion Subject &gt; = 18 year old Left ventricular ejection fraction â‰¤ 45 % evaluate transthoracic echocardiography ( Simpson 's method ) Carotid body present computer cervical angiotomography History exacerbate peripheral chemoreceptor sensitivity determine &gt; 0.6L/min/ % SpO2 Able willing give write informed consent Unstable angina pectoris , coronary attack , coronary revascularization , exacerbation heartfailure require hospitalization , clinically significant infection , surgery general anesthesia within 3 month prior inclusion History stroke , transient ischemic attack ( TIA ) , clinically significant chronic neurological disorder History heart transplant Pregnancy anticipation pregnancy Hemodialysis peritoneal dialysis patient Obstructive carotid atherosclerotic disease &gt; 50 % stenosis Severe sleep apnea syndrome diagnose PSG COPD stage III IV accord GOLD 2007 Unable perform spiroergometric assessment Any significant anomaly additional investigation may increase risk study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>carotid body</keyword>
	<keyword>heart failure</keyword>
	<keyword>chemoreceptor</keyword>
	<keyword>hypersensitivity</keyword>
</DOC>